Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism HASPIN inhibitors(histone H3 associated protein kinase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | KR | 12 Sep 2023 |